Literature DB >> 11292664

VEGFR3 gene structure, regulatory region, and sequence polymorphisms.

K Iljin1, M J Karkkainen, E C Lawrence, M A Kimak, M Uutela, J Taipale , K Pajusola, L Alhonen, M Halmekytö, D N Finegold, R E Ferrell, K Alitalo.   

Abstract

Vascular endothelial growth factor receptor 3 (VEGFR-3) is required for cardiovascular development during embryogenesis. In adults, this receptor is expressed in lymphatic endothelial cells, and mutant VEGFR3 alleles have been implicated in human hereditary lymphedema. To better understand the basis of its specific endothelial lineage-restricted expression, we have characterized the VEGFR3 gene and its regulatory 5' flanking region. The human gene contains 31 exons, of which exons 30a and 30b are alternatively spliced. The VEGFR3 proximal promoter is TATA-less and contains stretches of sequences homologous with the mouse Vegfr3 promoter region. In transfection experiments of cultured cells, the Vegfr3 promoter was shown to control endothelial cell-specific transcription of downstream reporter genes. This result was further confirmed in vivo; in a subset of transgenic mouse embryos, a 1.6 kb Vegfr3 promoter fragment directed weak lymphatic endothelial expression of the LacZ marker gene. This suggests that endothelial cell-specific elements occur in the proximal promoter, although further enhancer elements are probably located elsewhere. The sequence, organization, and variation in the VEGFR3 gene and its regulatory region provide important tools for the molecular genetic analysis of the lymphatic system and its disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292664     DOI: 10.1096/fj.00-0383com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse.

Authors:  Inho Choi; Hee Kyoung Chung; Swapnika Ramu; Ha Neul Lee; Kyu Eui Kim; Sunju Lee; Jaehyuk Yoo; Dongwon Choi; Yong Suk Lee; Berenice Aguilar; Young-Kwon Hong
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

2.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

3.  Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19).

Authors:  Ryosuke Shirasaki; Haruko Tashiro; Yoko Oka; Toshihiko Sugao; Tadashi Yamamoto; Mayumi Yoshimi; Nobu Akiyama; Kazuo Kawasugi; Naoki Shirafuji
Journal:  Int J Hematol       Date:  2011-07-06       Impact factor: 2.490

4.  Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels.

Authors:  Yael Kenig-Kozlovsky; Rizaldy P Scott; Tuncer Onay; Isabel Anna Carota; Benjamin R Thomson; Hyea Jin Gil; Veronica Ramirez; Shinji Yamaguchi; Christine E Tanna; Stefan Heinen; Christine Wu; Radu V Stan; Janet D Klein; Jeff M Sands; Guillermo Oliver; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2017-12-13       Impact factor: 10.121

5.  A model for gene therapy of human hereditary lymphedema.

Authors:  M J Karkkainen; A Saaristo; L Jussila; K A Karila; E C Lawrence; K Pajusola; H Bueler; A Eichmann; R Kauppinen; M I Kettunen; S Yla-Herttuala; D N Finegold; R E Ferrell; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

6.  Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3.

Authors:  Johannes Hertel; Christoph Hirche; Christoph Wissmann; Matthias P Ebert; Michael Höcker
Journal:  Cell Oncol (Dordr)       Date:  2014-04-08       Impact factor: 6.730

7.  Angiopoietin-2 in experimental colitis.

Authors:  Vijay C Ganta; Walter Cromer; Ginny L Mills; James Traylor; Merilyn Jennings; Sarah Daley; Benjamin Clark; J Michael Mathis; Michael Bernas; Moheb Boktor; Paul Jordan; Marlys Witte; J Steven Alexander
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

8.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Authors:  Michael J Flister; Andrew Wilber; Kelly L Hall; Caname Iwata; Kohei Miyazono; Riccardo E Nisato; Michael S Pepper; David C Zawieja; Sophia Ran
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

9.  Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.

Authors:  Alexandre Irrthum; Koenraad Devriendt; David Chitayat; Gert Matthijs; Conrad Glade; Peter M Steijlen; Jean-Pierre Fryns; Maurice A M Van Steensel; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2003-05-08       Impact factor: 11.025

10.  Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression.

Authors:  Carrie J Shawber; Yasuhiro Funahashi; Esther Francisco; Marina Vorontchikhina; Yukari Kitamura; Stephanie A Stowell; Valeriya Borisenko; Nikki Feirt; Simona Podgrabinska; Kazuko Shiraishi; Kallayanee Chawengsaksophak; Janet Rossant; Domenico Accili; Mihaela Skobe; Jan Kitajewski
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.